{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-062038","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.161637+00:00","generated_at":"2026-06-08T06:29:00.533378+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcadia Biosciences Q3 2023 revenue $1.6M, net loss $2.6M, launches GoodWheat Mac & Cheese","bullets":["Revenue from continuing ops $1.597M, up 20% QoQ; net loss $2.567M ($1.89/sh) vs $2.867M ($4.67/sh) in Q3 2022.","GoodWheat Mac & Cheese launching in three varieties; shipping to retailers Nov 2023, e-commerce Feb 2024.","SG&A expenses $3.443M, lowest since 2019, down from $4.178M in Q3 2022.","Positive gross profit from continuing ops for seventh consecutive quarter; cash $10.6M, short-term investments $5.1M.","Nine-month net loss $11.128M ($9.31/sh) vs $11.132M ($19.37/sh) a year ago; weighted shares 1.195M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-062038","json":"https://secwatch.observer/filing/0000950170-23-062038.json","markdown":"https://secwatch.observer/filing/0000950170-23-062038.md","text":"https://secwatch.observer/filing/0000950170-23-062038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023062038/0000950170-23-062038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023062038/rkda-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:29:00.533378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c75f4de2fc773110b368fb1f9095e3e2719dd54c","claim":"Arcadia Biosciences, Inc. reported the third quarter ended September 30, 2023 results: revenue 1,597, net income (2,567), EPS $1.89 per share.","evidence_excerpt":"($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 Favorable / (Unfavorable) 2023 2022 Favorable / (Unfavorable) $ % $ % Total revenues 1,597 1,570 27 2% 4,160 6,674 (2,514) (38%) Total operating expenses 4,839 5,561 722 13% 14,734 16,023 1,289 8% Loss from continuing operations (3,242) (3,991) 749 19% (10,574) (9,349)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023062038/0000950170-23-062038-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"1,597"},{"label":"Net income","value":"(2,567)"},{"label":"EPS","value":"$1.89 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}